PLAUR and colorectal carcinoma: The combined amount of the soluble uPAR-forms in plasma from CRC patients is a strong prognostic marker with high levels correlating to poor prognosis 12, and interestingly the liberated uPAR(I) and the uPAR(I–III) + uPAR(II–III) are independent prognostic markers 13.